Showing results (11-20 of 760) with videos related to
Sort By:
Pageof 76
Current Opinion in Molecular Therapeutics|August 4, 2009
Rilotumumab, a mAb against human hepatocyte growth factor for the treatment of cancerSilvia GiordanoTrends in Molecular Medicine|June 5, 2016
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?Simona Corso, Silvia GiordanoJournal of Hepatology|September 19, 2013
Met as a therapeutic target in HCC: facts and hopesSilvia Giordano, Amedeo ColumbanoHepatology (Baltimore, Md.)|October 20, 2012
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?Silvia Giordano, Amedeo ColumbanoCancer Discovery|August 1, 2013
Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspectiveSimona Corso, Silvia GiordanoCurrent Opinion in Pharmacology|June 26, 2013
Targeting MET: why, where and how?Elena Ghiso, Silvia GiordanoCurrent Opinion in Cell Biology|March 22, 2003
Negative receptor signallingIvan Dikic, Silvia GiordanoEuropean Journal of Cancer (Oxford, England : 1990)|February 26, 2008
Molecular cancer therapy: can our expectation be MET?Cristina Migliore, Silvia GiordanoTrends in Molecular Medicine|September 10, 2013
Resistance to targeted therapies: a role for microRNAs?Cristina Migliore, Silvia GiordanoPageof 76